Transfusion practice in a Canadian hospital. Use of a major European study of transfusion practice for comparison as a form of audit.
Blood transfusion practices in a Canadian hospital have been compared, as a form of audit, to those reported in a multi-hospital study in Europe, to identify possible deviations from desirable practice. Blood product use for four surgical procedures: laparatomic cholecystectomy, total hip replacement, coronary artery bypass graft (CABG) and abdominal aortic aneurysmectomy (AAA), was determined from this hospital's blood bank data base, and is compared to use for the same procedures in European hospitals. Blood product use here is less than in the majority of European centres, in respect of red cells for all four procedures and plasma for CABG and AAA. Platelet use in association with CABG and AAA is greater than the majority of European centres reporting data. As a consequence, platelet use here will be subjected to closer review.